Nuvalent (NUVL) Other Non Operating Income (2020 - 2026)
Nuvalent (NUVL) reported Other Non Operating Income of -$2.6 million for Q1 2026, down 79.72% on a YoY basis from -$12.7 million in Q1 2025, and up 90.8% quarter-over-quarter from -$27.9 million in Q4 2025.
Nuvalent (NUVL) Other Non Operating Income (2020 - 2026) Analysis & Trends
Nuvalent has reported Other Non Operating Income for 6 years, with the latest figure at -$2.6 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 79.72% year-over-year to -$2.6 million; the trailing twelve-month figure through Mar 2026 stood at -$56.4 million (down 190.97% YoY), and the FY2025 full-year result was -$55.2 million, down 207.8% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$2.6 million, up from -$27.9 million in the prior quarter.
- The five-year high for Other Non Operating Income was $672000.0 in Q3 2022, with the low at -$27.9 million in Q4 2025.
- Historically, Other Non Operating Income has averaged -$6.9 million across 4 years, with a median of -$1.4 million in 2025.
- Annual changes were most pronounced in 2022 — Other Non Operating Income soared 67100.0% — and 2025, when it plunged 1985.07%.
- Nuvalent's Other Non Operating Income stood at -$1.1 million in 2022, then slipped by 24.3% to -$1.3 million in 2024, then sank by 1985.07% to -$27.9 million in 2025, then jumped by 90.8% to -$2.6 million in 2026.
- The last three Other Non Operating Income figures came in at -$2.6 million (Q1 2026), -$27.9 million (Q4 2025), and -$19.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Nuvalent | 9.70 Bn | 9.70 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.57 Mn |
| Dec 31, 2025 | -27.94 Mn |
| Sep 30, 2025 | -19.81 Mn |
| Jun 30, 2025 | -6.04 Mn |
| Mar 31, 2025 | -1.43 Mn |
| Dec 31, 2024 | -1.34 Mn |
| Sep 30, 2024 | -16.60 Mn |
| Dec 31, 2022 | -1.08 Mn |
| Sep 30, 2022 | 672,000.00 |
| Jun 30, 2022 | 267,000.00 |
| Mar 31, 2022 | 139,000.00 |
| Dec 31, 2021 | 89,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Mar 31, 2021 | 12,000.00 |
| Dec 31, 2020 | -3,000.00 |
| Sep 30, 2020 | -14,000.00 |
| Jun 30, 2020 | -9,000.00 |